When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives

by Scott D. Grosse
Published 2015-09-01

Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis

by Scott D. Grosse
Published 2015-11-01

Monetary Valuation of Children’s Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review

by Scott D. Grosse, Ying Zhou
Published 2021-04-01

Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia

by Scott D. Grosse, Guy Van Vliet
Published 2020-10-01

A practical guide to episode groupers for cost-of-illness analysis in health services research

by Cora Peterson, Scott D Grosse, Abe Dunn
Published 2019-03-01

Correction: Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010.

by Brandi M Dupervil, Scott D Grosse, Arthur L Burnett, Christopher S Parker
Published 2016-01-01

Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review

by Scott D. Grosse, Cora Peterson, Rahi Abouk, Jill Glidewell, Matthew E. Oster
Published 2017-12-01

Spending by California's Department of Developmental Services for Persons with Autism across Demographic and Expenditure Categories.

by J Paul Leigh, Scott D Grosse, Diana Cassady, Joy Melnikow, Irva Hertz-Picciotto
Published 2016-01-01

What Contribution Did Economic Evidence Make to the Adoption of Universal Newborn Hearing Screening Policies in the United States?

by Scott D. Grosse, Craig A. Mason, Marcus Gaffney, Vickie Thomson, Karl R. White
Published 2018-07-01

Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease

by Lisa A. Prosser, K. K. Lam, Scott D. Grosse, Mia Casale, Alex R. Kemper
Published 2018-04-01

Correlates of in-hospital deaths among hospitalizations with pulmonary embolism: findings from the 2001-2008 National Hospital Discharge Survey.

by James Tsai, Scott D Grosse, Althea M Grant, Nimia L Reyes, W Craig Hooper, Hani K Atrash
Published 2012-01-01

Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis.

by James Tsai, Althea M Grant, Michele G Beckman, Scott D Grosse, Hussain R Yusuf, Lisa C Richardson
Published 2015-01-01

The financial and time burden associated with phenylketonuria treatment in the United States

by Angela M. Rose, Scott D. Grosse, Sandra P. Garcia, Janice Bach, Mary Kleyn, Norma-Jean E. Simon, Lisa A. Prosser
Published 2019-12-01

Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016

by Rui Li, Katharine B. Simmons, Jeanne Bertolli, Brenda Rivera-Garcia, Shanna Cox, Lisa Romero, Lisa M. Koonin, Miguel Valencia-Prado, Nabal Bracero, Denise J. Jamieson, Wanda Barfield, Cynthia A. Moore, Cara T. Mai, Lauren C. Korhonen, Meghan T. Frey, Janice Perez-Padilla, Ricardo Torres-Muñoz, Scott D. Grosse
Published 2017-01-01

Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada

by Maria D. Karaceper, Sara D. Khangura, Kumanan Wilson, Doug Coyle, Marni Brownell, Christine Davies, Linda Dodds, Annette Feigenbaum, Deshayne B. Fell, Scott D. Grosse, Astrid Guttmann, Steven Hawken, Robin Z. Hayeems, Jonathan B. Kronick, Anne-Marie Laberge, Julian Little, Aizeddin Mhanni, John J. Mitchell, Meranda Nakhla, Murray Potter, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Sylvia Stockler, Keiko Ueda, Hilary Vallance, Brenda J. Wilson, Pranesh Chakraborty, Beth K. Potter, in collaboration with the Canadian Inherited Metabolic Diseases Research Network (CIMDRN)
Published 2019-03-01